CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($) $ in Thousands	Total	Series B Preferred Stock	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interest
Beginning Balances at Dec. 31, 2017	$ 23,853	$ 3	$ 15	$ 428,470	$ (7,485)	$ (399,647)	$ 2,675	$ (178)
Beginning Balances (in shares) at Dec. 31, 2017		3,000,000	14,436,000
Net loss	(5,333)					(5,338)		5
Other comprehensive loss	(526)						(529)	3
Impact of adoption of Topic 606 (Note 2) | Topic 606	2					2
Issuance of Series B preferred stock, net of issuance costs	7,895	$ 2		7,893
Issuance of Series B preferred stock, net of issuance costs (shares)		2,000,000
Issuance of common stock in connection with acquisition of business	2,635		$ 1	2,634
Issuance of common stock in connection with acquisition of business (shares)			723,000
Issuance of common stock in connection with vesting of stock awards (shares)			394,000
Proceeds from exercise of stock options	$ 13			13
Proceeds from exercise of stock options (shares)	2,500		3,000
Stock-based compensation	$ 1,987			1,987
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units	(502)				(502)
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (Shares)			(110,000)
Issuance of shares to non- employees	11			11
Issuance of shares to non-employees (shares)			3,000
Ending Balances at Sep. 30, 2018	$ 30,035	$ 5	$ 16	$ 441,008	$ (7,987)	$ (404,983)	$ 2,146	$ (170)
Ending Balances (in shares) at Sep. 30, 2018		5,000,000	15,449,000